Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.59 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 4/20 | 0.56 |
| ▸ | SCN3A | Q9NY46 | 3/20 | 0.56 |
| ▸ | LMNA | P02545 | 3/20 | 0.56 |
| ▸ | SCN1A | P35498 | 2/20 | 0.56 |
| ▸ | SCN2A | Q99250 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.56 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.56 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.56 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.56 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.56 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.56 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.56 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8622854 | 0.98 | MEN1 (0.57) | MEN1KMT2ACYP1A2CYP2C9CYP2C19 | |
| SCHEMBL21765473 | 0.84 | MEN1 (0.57) | MEN1KMT2ACYP1A2CYP2C9CYP2C19 | |
| SCHEMBL11723693 | 0.81 | HPGD (0.51) | KMT2ACYP2C19MAPTLMNAALDH1A1 | |
| SCHEMBL2093587 | 0.81 | LMNA (0.61) | MEN1KMT2AMAPTLMNAALDH1A1 | |
| SCHEMBL7547745 | 0.80 | SMN1; SMN2 (0.71) | MEN1KMT2AMAPTLMNAALDH1A1 | |
| SCHEMBL11085927 | 0.79 | CYP2C19 (0.46) | CYP1A2CYP2C19MAPTLMNAALDH1A1 | |
| SCHEMBL10567645 | 0.79 | MAPT (0.66) | MEN1KMT2ACYP1A2CYP2C9CYP2C19 | |
| SCHEMBL5892506 | 0.79 | KMT2A (0.65) | MEN1KMT2ACYP1A2CYP2C9CYP2C19 | |
| SCHEMBL28164480 | 0.78 | MEN1 (0.53) | MEN1KMT2ACYP1A2CYP2C9CYP2C19 | |
| Glycinexylidide SCHEMBL4107220 | 0.77 | LMNA (0.65) | MEN1KMT2ACYP1A2CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113979880-A | Novel method for preparing dimethachlor | 上海农帆生物科技有限公司 | 2022-01-28 | — | — | CN | claimed |
| CN-114716341-B | Method for preparing dimethenamid by one-pot method | 上海农帆生物科技有限公司 | 2024-05-03 | — | — | CN | disclosed |
| CN-111995539-B | Preparation method of lidocaine hydrochloride impurity E | 郑州原理生物科技有限公司 | 2023-08-11 | — | — | CN | disclosed |
| CN-114716341-A | Method for preparing dimethachlor by one-pot method | 上海农帆生物科技有限公司 | 2022-07-08 | — | — | CN | disclosed |
| WO-2022051804-A1 | COMPOUNDS AND METHODS | THE UNIVERSITY OF WESTERN AUSTRALIA (AU) | 2022-03-17 | — | — | WO | disclosed |
| CN-113979880-A | Novel method for preparing dimethachlor | 上海农帆生物科技有限公司 | 2022-01-28 | — | — | CN | disclosed |
| CN-113979880-A | Novel method for preparing dimethachlor | 上海农帆生物科技有限公司 | 2022-01-28 | — | — | CN | disclosed |
| CN-111995539-A | Preparation method of lidocaine hydrochloride impurity E | 郑州原理生物科技有限公司 | 2020-11-27 | — | — | CN | disclosed |
| US-20120190542-A1 | FUNGICIDAL MIXTURES AND THEIR USE | SYNGENTA CROP PROTECTION, LLC (US) | 2012-07-26 | — | — | US | disclosed |
| EP-0643687-B1 | IMPROVED PROCESS FOR PREPARING N-PHENYL-N-METHOXYACETYL-DL-ALANINE METHYL ESTER DERIVATIVES | NITROKEMIA IPARTELEPEK (HU) | 1998-06-10 | — | — | EP | disclosed |
| US-5639905-A | REACTING N-METHOXYACETYL DERIVATIVE WITH ALKALI METAL ALKOXIDE, REACTING THE METAL SALT WITH METHYL HALOPROPIONATE | NITROKEMIA IPARTELEPEK (HU) | 1997-06-17 | — | — | US | disclosed |
| EP-0643687-A1 | IMPROVED PROCESS FOR PREPARING N-PHENYL-N-METHOXYACETYL-DL-ALANINE METHYL ESTER DERIVATIVES | NITROKEMIA IPARTELEPEK (HU) | 1995-03-22 | — | — | EP | disclosed |
| WO-1993020041-A1 | IMPROVED PROCESS FOR PREPARING N-PHENYL-N-METHOXYACETYL-DL-ALANINE METHYL ESTER DERIVATIVES | NITROKÉMIA IPARTELEPEK (HU) | 1993-10-14 | — | — | WO | disclosed |
| EP-0423282-B1 | PROCESS FOR PREPARING N-PHENYL-N-METHOXYACETYL-DL-ALANINE-METHYLESTER DERIVATIVES | NITRO-KEMIA IPARTELEPEK (HU) | 1993-08-04 | — | — | EP | disclosed |
| WO-1990012783-A1 | PROCESS FOR PREPARING N-PHENYL-N-METHOXYACETYL-DL-ALANINE-METHYLESTER DERIVATIVES | NITROKÉMIA IPARTELEPEK (HU) | 1990-11-01 | — | — | WO | disclosed |
| EP-0019858-B1 | N-OXIMINOALKYL ANILIDES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS FUNGICIDES | BAYER AG (DE) | 1983-06-22 | — | — | EP | disclosed |
| US-4337268-A | MICROBIOCIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1982-06-29 | — | — | US | disclosed |
| EP-0010673-B1 | SUBSTITUTED N-PROPARGYL ANILINES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS FUNGICIDES | BAYER AG (DE) | 1982-01-27 | — | — | EP | disclosed |
| EP-0019858-A2 | N-Oximinoalkyl anilides, process for their preparation and their use as fungicides | BAYER AG (DE) | 1980-12-10 | — | — | EP | disclosed |
| EP-0010673-A2 | Substituted N-propargyl anilines, process for their preparation and their use as fungicides | BAYER AG (DE) | 1980-05-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120190542-A1 | FUNGICIDAL MIXTURES AND THEIR USE | MLN, P2RY13, P2RX2 | MEN1 1090/4885KMT2A 2660/4885CYP1A2 51/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.